ID   CB-NJR
AC   CVCL_Y580
DR   Wikidata; Q54808643
RX   PubMed=2302710;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   From: Reynolds, Charles Patrick; Children's Hospital of Los Angeles; Los Angeles; USA.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
RX   PubMed=2302710;
RA   Ozkaynak M.F., Nolta J., Parkman R.;
RT   "In vitro purging of human rhabdomyosarcoma cells using
RT   4-hydroperoxycyclophosphamide.";
RL   Cancer Res. 50:1455-1458(1990).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//